Choose the right coronavirus test based on your needs

Please log in for more information

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Mobidiag UK
Aston Court, Kingsmead Business Park,
Frederick Place, High Wycombe
Buckinghamshire, HP11 1LA
UK
+44 (0) 333 305 7506
[email protected]

Mobidiag offers molecular diagnostic solutions for Gastrointestinal, Respiratory (including COVID-19) and Healthcare Associated Infections, as well as Antimicrobial Resistance Management suited for each laboratory needs and capacities.

With its 2 complementary platforms Amplidiag® and Novodiag®, Mobidiag has the capacity to meet the needs of clinical laboratories and multiple healthcare settings. Currently on the market, these platforms combine high quality and affordable costs, allowing widespread use both in mass screening and on-demand highly targeted or syndromic tests.

Pillar Biosciences’ oncoReveal™ CDx Pan-Cancer Solid Tumor IVD: A Rapid FDA Approved NGS Kit to Help Drive Actionable and Accessible Localized Testing.

10/23/2024 | Sponsored by Illumina